Tecartus (brexucabtagene autoleucel) is a genetically modified T cell immunotherapy medicine.
Tecartus is used to treat mantle cell lymphoma in adults. This medicine is given after other treatments did not work or have stopped working.
Tecartus is made using white blood cells removed from blood that is drawn from your body through a vein.
